These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Postischemic administration of angiotensin II type 1 receptor blocker reduces cerebral infarction size in hypertensive rats. Omura-Matsuoka E; Yagita Y; Sasaki T; Terasaki Y; Oyama N; Sugiyama Y; Okazaki S; Sakoda S; Kitagawa K Hypertens Res; 2009 Jul; 32(7):548-53. PubMed ID: 19424281 [TBL] [Abstract][Full Text] [Related]
65. No effect of angiotensin II AT(2)-receptor antagonist PD 123319 on cerebral blood flow autoregulation. Estrup TM; Paulson OB; Strandgaard S J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):188-92. PubMed ID: 11881121 [TBL] [Abstract][Full Text] [Related]
66. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 3rd communication: effect on postischemic cerebral blood flow and metabolism, and ischemic neuronal cell death. Szabo L; Hofmann HP Arzneimittelforschung; 1989 Mar; 39(3):314-9. PubMed ID: 2757657 [TBL] [Abstract][Full Text] [Related]
67. Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke. Li L; Jiang Q; Zhang L; Ding G; Gang Zhang Z; Li Q; Ewing JR; Lu M; Panda S; Ledbetter KA; Whitton PA; Chopp M Brain Res; 2007 Feb; 1132(1):185-92. PubMed ID: 17188664 [TBL] [Abstract][Full Text] [Related]
68. [Means for the pharmacological regulation of the cerebral blood circulation]. Mirzoian RS Eksp Klin Farmakol; 1995; 58(4):3-7. PubMed ID: 7580749 [No Abstract] [Full Text] [Related]
69. [The effect of ethomersol on local cerebral blood flow and edema of the brain tissue in chronic ischemia]. Vaizova OE; Plotnikova TM; Plotnikov MB Eksp Klin Farmakol; 1994; 57(1):25-7. PubMed ID: 8142857 [TBL] [Abstract][Full Text] [Related]
70. [The effect of esafosfina on cerebral circulation in intact and ischemized rat brain]. Gan'shina TS; Aleksandrin VV; Mirzoian RS Eksp Klin Farmakol; 2004; 67(4):19-20. PubMed ID: 15500039 [TBL] [Abstract][Full Text] [Related]
71. [Effect of mexidol on the homeostasis and lipid peroxidation in paracetamol poisoning]. Katikova OIu Eksp Klin Farmakol; 2002; 65(6):53-6. PubMed ID: 12596535 [TBL] [Abstract][Full Text] [Related]
72. [The results of the study of the efficacy and safety of mexidol in patients with chronic cerebral ischemia]. Chukanova EI; Chukanova AS; Mamayeva KI Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(2):71-74. PubMed ID: 26081329 [TBL] [Abstract][Full Text] [Related]
73. [VESTIBULAR AND THERMOPROTECTIVE PROPERTIES OF A NEW ACTOPROTECTOR]. Yasnetsov VV; Tsublova EG; Yasnetsov VV; Skachilova SY; Karsanova SK; Chelnaya NA Aviakosm Ekolog Med; 2015; 49(6):29-32. PubMed ID: 26934787 [TBL] [Abstract][Full Text] [Related]
74. Disturbance of cerebral autoregulation after global ischemia and the stabilizing role of adenosine. Kolvenbach R; Nemat AT; Sandmann W Intensive Care Med; 1992; 18(4):252. PubMed ID: 1430594 [No Abstract] [Full Text] [Related]
78. [Results of the sequential use of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia]. Abramenko YV Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):59-64. PubMed ID: 32307432 [TBL] [Abstract][Full Text] [Related]
79. Neuroprotective activity of mexidole and 3-hydroxypyridine acetylcysteinate against the background of cerebral ischemia in the complex of experimental diabetes mellitus and exogenous hypercholesterolemia. Inchina VI; Bukina SJ Bull Exp Biol Med; 2008 Jun; 145(6):738-40. PubMed ID: 19110565 [TBL] [Abstract][Full Text] [Related]
80. [A modern concept of antihypoxic and antioxidant effects of mexidol]. Shchulkin AV Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(12. Vyp. 2):87-93. PubMed ID: 30830123 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]